# Study to Assess the Efficacy and Safety of Raxone in LHON Patients

> **NCT02774005** · PHASE4 · COMPLETED · sponsor: **Santhera Pharmaceuticals** · enrollment: 199 (actual)

## Conditions studied

- Leber's Hereditary Optic Neuropathy (LHON)

## Interventions

- **DRUG:** Idebenone

## Key facts

- **NCT ID:** NCT02774005
- **Lead sponsor:** Santhera Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2021-03-29
- **Final completion:** 2021-03-29
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2023-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02774005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02774005, "Study to Assess the Efficacy and Safety of Raxone in LHON Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02774005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*